Fingerprint
Dive into the research topics of 'Long-term molecular and cytogenetic response and survival outcomes with imatinib 400 mg, imatinib 800 mg, dasatinib, and nilotinib in patients with chronic-phase chronic myeloid leukaemia: Retrospective analysis of patient data from five clinical trials'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically